financetom
Market
financetom
/
Market
/
PSU banking pack by and large is a complete avoid, says Sudip Bandopadhyay
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PSU banking pack by and large is a complete avoid, says Sudip Bandopadhyay
Mar 22, 2018 4:09 AM

Investors should stay away from public sector banking stocks, Sudip Bandopadhyay, Group Chairman of Inditrade Capital said in a conversation with CNBC-TV18.

He said, "I think there are significant concerns around the entire PSU basket. Very clearly the Punjab National Bank (PNB) fraud has kind of shattered the confidence of the investors. So the entire recapitalisation related positive momentum and positive vibes in the PSU banking space which had been created, has absolutely disappeared. People are worried about the survival and the future of the PSU banking pack."

It is an extremely challenging position for the government as well, he said, adding, "We are not talking about recapitalisation, we are not talking about some amount of money coming here and there, we are talking about fundamental change in the way the banks operate. Unless that is done, I think it is extremely difficult for the confidence of the market to be restored back in the PSU banking space. There may be small trading opportunities here and there based on news flows, but for a fundamental investor, I think PSU banking pack by and large is a complete avoid," Bandopadhyay added.

He further said, "State Bank of India (SBI) is a slightly different animal. I think it is definitely much better managed, governed, and run bank among the PSU banks. If somebody has to take a bet on the PSU banking space, SBI is definitely the only possible buy. At current levels, it has significantly corrected. For a long term investor interested in PSU space, SBI is a good buy at current level."

First Published:Mar 22, 2018 12:09 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Equity Indexes Rebound After Trump Softens China Stance
US Equity Indexes Rebound After Trump Softens China Stance
Oct 13, 2025
01:35 PM EDT, 10/13/2025 (MT Newswires) -- US equity indexes jumped after midday Monday as President Donald Trump softened China tariff threats and a deal between Broadcom ( AVGO ) and OpenAI boosted the so-called AI trade. The Nasdaq Composite jumped 2.1% to 22,666.5, with the S&P 500 up 1.6% to 6,655.4 and the Dow Jones Industrial Average 1.3% higher...
Sector Update: Tech Stocks Gain Monday Afternoon
Sector Update: Tech Stocks Gain Monday Afternoon
Oct 13, 2025
01:41 PM EDT, 10/13/2025 (MT Newswires) -- Tech stocks were higher Monday afternoon, with the Technology Select Sector SPDR Fund (XLK) rising 2.6% and the SPDR S&P Semiconductor ETF (XSD) surging 6.6%. The Philadelphia Semiconductor index climbed 5.1%. In corporate news, Broadcom ( AVGO ) and OpenAI, which counts Microsoft ( MSFT ) as a major investor, said Monday that...
Sector Update: Financial Stocks Rise Monday Afternoon
Sector Update: Financial Stocks Rise Monday Afternoon
Oct 13, 2025
01:40 PM EDT, 10/13/2025 (MT Newswires) -- Financial stocks were higher in Monday afternoon trading, with the NYSE Financial Index rising 1.1% and the Financial Select Sector SPDR Fund (XLF) up 1%. The Philadelphia Housing Index increased marginally, and the Real Estate Select Sector SPDR Fund (XLRE) rose 0.3%. Bitcoin (BTC-USD) was declining 0.2% to $114,852, and the yield for...
Sector Update: Health Care Stocks Advance Monday Afternoon
Sector Update: Health Care Stocks Advance Monday Afternoon
Oct 13, 2025
01:42 PM EDT, 10/13/2025 (MT Newswires) -- Health care stocks rose Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.3%. The iShares Biotechnology ETF (IBB) climbed 1.1%. In corporate news, AbbVie ( ABBV ) shares rose 0.7% after it said Monday that the US Food and Drug Administration has...
Copyright 2023-2026 - www.financetom.com All Rights Reserved